On July 11, 2025, the House Appropriations Committee released its Fiscal Year (FY) 2026 Commerce, Justice, Science, and Related Agencies (CJS) appropriations bill, which includes funding levels for key federal programs addressing substance use and the opioid epidemic. The proposal reflects continued bipartisan support for community-based prevention, treatment, and recovery efforts, with modest increases to select programs. CARA and COSSUP Programs The bill increases funding f

Chestnut Health Systems has launched a new resource to support community-engaged research. The free toolkit, Community-Engaged Substance...

This webinar focused on evaluating and sustaining public health communications campaigns. Presenters discussed evaluation approaches for...

President Donald Trump today signed the Halt All Lethal Trafficking of (HALT) Fentanyl Act into law in July 2025, permanently classifying illicit, fentanyl-related substances as Schedule I.

Cannabis use has become increasingly normalized and legalized across the globe, but its impact on mental health is still being understood. A recent systematic review and meta-analysis published in Drug and Alcohol Dependence delves into the complex relationship between cannabis use, depression, and suicidal behavior. Cannabis use has been found to be a risk factor for depression, and consistent cannabis use has been associated with suicidality, suicidal behaviors, and action

In a new article published in JAMA, JCOIN researchers found that 27.6% of United States jails offer all three FDA-approved medications for opioid use disorder (MOUD).